Chinese health regulator says cancer drug prices could more than halve
MLex Summary: The prices of imported patented drugs used to treat major diseases and cancers could be reduced by more than 50 percent following negotiations that involve the government and other...To view the full article, register now.
Already a subscriber? Click here to view full article